Saturday, March 28, 2020 9:20:47 PM
Preventive treatment of people after contact with infected or showing signs of infection - oseltamivir (Tamiflu; Tamivil, Ebilfumin) 0.075 1x1 + doxycyclinum (Unidox solutab, Doxycyclinum) 0.1 1x1; treatment of symptomatic patients both drugs 2x1. After the symptoms disappear, 1x1 again for up to 2 weeks. Oseltamivir, a neuraminidase inhibitor, inhibits the virus from entering and leaving the cell, thereby inhibiting the spread of the virus in the body; Doxycycline, a modified tetracycline, has an adjunctive effect on inhibiting protein biosynthesis by binding to the 30S ribosome subunit and phosphorylation processes in infected cells (inhibition of capsid formation around the viral nucleic acid, i.e. viral envelope).
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM